Mayo Clinic Tapestry 2.0: Applying Multi-Omics for Scientific Discovery
- Conditions
- Genetic PredispositionExposure, Environmental
- Registration Number
- NCT06456320
- Lead Sponsor
- Mayo Clinic
- Brief Summary
The purpose of this study is to use multi-omics testing on samples collected from Mayo Clinic patients to build and expand on what has been learned about genomic data.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ENROLLING_BY_INVITATION
- Sex
- All
- Target Recruitment
- 50000
Inclusion Criteria
- Age ≥ 18 years
- Registered Mayo Clinic patient
- Able to provide informed written consent
- Able to receive mail and packages within a United States (US) state
- Able to collect and ship samples within a US state
Exclusion Criteria
- Active hematological cancer or history of a hematological cancer
- Allogeneic Bone Marrow Transplant (e.g., samples from autologous bone marrow transplant recipients are acceptable if collected at least one month after transplant)
- Other co-morbidity that, in physician's opinion, would interfere with patient's ability to participate in the study (e.g., reduced ability to comprehend, i.e., dementia, intellectual disability, etc.)
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Creation of a unique integrated asset of multi-omics data Up to 5 years A variety of patient cohorts will be ascertained throughout this study. Data will be made available to researchers to query correlations of disease states and clinical outcomes to multi-omics findings. These insights will be invaluable to creating omics-informed care plans in the future. Standard descriptive statistics approaches will be used for analysis.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (3)
Mayo Clinic in Florida
🇺🇸Jacksonville, Florida, United States
Mayo Clinic in Arizona
🇺🇸Scottsdale, Arizona, United States
Mayo Clinic in Rochester
🇺🇸Rochester, Minnesota, United States